pediatric patient / parent

Treatment Approaches in AML: Key Testing for Personalized Care

Original Publication Date
Article Source
External Web Content
VIDEO Description: Treatment Approaches in AML: Key Testing for Personalized Care from Patient Empowerment Network on Vimeo. When it comes to Acute Myeloid Leukemia (AML), genetic testing (or biomarker testing) is essential in helping to determine the best treatment approach for…

ASH Issues Guidelines on Newly Diagnosed AML in Older Adults

Original Publication Date
Article Source
External Web Content
In evidence-based guidelines issued by the American Society of Hematology and published in the Aug. 11 issue of Blood Advances, recommendations are presented for the management of newly diagnosed acute myeloid leukemia (AML) in older adults. Mikkael A. Sekeres, M.D., from the…

Mychaela Dances Again, Thanks to her Mother's Advocacy

My name is Mychaela Lovelace. I had been a healthy five-year-old child until one day, when I came home, my mother noticed red dots and bruises on my body. Because she worked in the medical field, she was very concerned. She took me to the doctor, but my pediatrician wasn’t on in the office that day. The doctor I didn’t know said that I was just playing too hard and the dots and bruises were just a rash.

Community Rallied around Braeden's Family as he Fought Aplastic Anemia --- Now Family "Pays it Forward"

“Hey, Braeden, we need to go.”   
Little did 12-year-old Braden understand that he was headed towards hospital admission.

Earlier that day, Braden nearly passed out on the basketball court. He was a happy, athletic child, who excelled at several sports.  His mom, Becki, took him for blood work.

Later, Braeden’s parents heard from the doctor’s office: take him to the Emergency Department now.  That’s when Braeden’s dad came to pick him up from his friend’s house, where he’d been playing normally.

Joseph Oved, MD

Institution
Memorial Sloan-Kettering Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Pediatric
About
Dr. Oved completed scientific and clinical training that included tenures as a Fulbright Fellow with the Weizmann Institute in Israel, the NYU School of Medicine with two years as a Howard Hughes Medical Fellow, followed by a residency in Pediatrics at NYP Weill Cornell Medical College. During his residency, he developed an interest in more translational questions working with Dr. James Bussel to test a novel combination of dexamethasone and rituximab for pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP).

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.